We do not order sleep studies. You must provider these results.
Services Included:
Services Included:
Services Included:
A consult does not guarantee a prescription. Please review the program exclusions prior to booking.
Recently, the FDA approved Zepbound (Tirzepatide) for the treatment of moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity. Tirzepatide, previously approved for obesity under brand name Zepbound works by mimicking hormones that regulate appetite and blood sugar levels. Clinical trials showed that Zepbound significantly reduced breathing disruptions during sleep and helped with weight loss.
Obstructive Sleep Apnea (OSA) is a sleep disorder where breathing repeatedly stops and starts. The most common type, Obstructive Sleep apnea, occurs when throat muscles relax and block the airway during sleep. Symptoms include loud snoring, episodes of stopped breathing during sleep, gasping for air, and excessive daytime sleepiness. Obesity is a main contributor to OSA.
Our combined sleep and obesity program offers treatment with FDA approved prescription Zepbound injections to treat your diagnosed obstructive sleep apnea and obesity. Our goal is to enhance the quality of life for individuals with obstructive sleep apnea by providing an effective weight loss program with FDA approved prescription treatment Zepbound.
At your initial consult you will meet a licensed medical provider that will evaluate your medical history to see if you are able to be prescribed Zepbound for treatment of your obstructive sleep apnea. Our program includes comprehensive lab review, personalized health evaluations, and continuous support. We aim to empower our patients with the tools and knowledge they need to achieve sustainable health outcomes.
Copyright © 2025 ICARENP LLC